Loading: 100%
Allergan Inc. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 16,700 (as per FY 2014)no data available
Sector Drug Manufacturers, HealthcareDrug Manufacturers, Healthcareno data available
Ticker AGNno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17180200220240260
datesClosing price (adj.)
13.10.2017205.52
11.10.2017206.61
04.10.2017208.39
27.09.2017208.30
20.09.2017210.00
13.09.2017226.47
06.09.2017223.61
30.08.2017223.86
23.08.2017222.27
16.08.2017227.99
09.08.2017237.24
02.08.2017249.41
26.07.2017255.37
19.07.2017245.66
12.07.2017244.84
05.07.2017243.54
27.06.2017245.34
20.06.2017237.90
13.06.2017230.08
06.06.2017227.61
30.05.2017221.43
23.05.2017219.98
16.05.2017223.86
09.05.2017237.04
02.05.2017243.99
25.04.2017236.75
18.04.2017232.94
11.04.2017237.64
04.04.2017236.96
28.03.2017239.05
21.03.2017233.11
14.03.2017237.98
07.03.2017238.12
28.02.2017243.31
21.02.2017244.94
14.02.2017246.34
07.02.2017230.52
31.01.2017216.92
24.01.2017211.19
17.01.2017212.85
10.01.2017219.26
03.01.2017214.25
27.12.2016198.69
19.12.2016190.82
12.12.2016189.05
05.12.2016189.46
28.11.2016188.28
21.11.2016189.42
14.11.2016200.28
07.11.2016197.66
31.10.2016207.06
24.10.2016223.90
17.10.2016221.98
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
205.52n/a
Market Capitalisation
in million USD
63,219n/a
Enterprise Value
in million USD
60,420n/a
Common Shares Outstanding
as per Oct 31, 2014
307,605,860n/a
Preferred Shares Outstanding
as per Oct 31, 2014
n/a
Average Basic Shares Outstanding
TTM
297,600,000n/a
Average Diluted Shares Outstanding
TTM
304,000,000n/a
Index Membership
n/a
Business Summary
Allergan PLC is a specialty pharmaceutical company engaged in the development, manufacturing, marketing, and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and OTC pharmaceutical products.
no data available
Key Financials & Ratios (all figures TTM as per Dec 31, 2014, million USD, full statements further below)
Profit & Loss
Revenues 7,238n/a
Gross Profit 6,396n/a
Operating Income 2,254n/a
EBITDA 2,502n/a
Net Profit 1,524n/a
Balance Sheet
Cash and Cash Equivalents 4,966n/a
Receivables 915n/a
Total Current Assets 6,871n/a
PP&E 1,006n/a
Total Assets 12,416n/a
Accounts Payable 287n/a
Current Debt 72n/a
Total Current Liabilities 1,557n/a
Long-Term Debt 2,085n/a
Total Liabilities 4,653n/a
Total Equity 7,763n/a
Cash Flow
Depreciation & Amortisation 248n/a
Change in Working Capital -193n/a
Operating Cash Flow 1,928n/a
Net Change in PP&E and Intangibles -258n/a
Investing Cash Flow 183n/a
Dividends Paid -60n/a
Financing Cash Flow -204n/a
Total Change in Cash 1,865n/a
Free Cash Flow 1,594n/a
Profitability Ratios
Gross Margin 88.4%n/a
Operating Margin 31.2%n/a
Net Profit Margin 21.1%n/a
Return on Equity 19.7%n/a
Return on Assets 12.3%n/a
Per Share Figures
Basic EPS 5.12n/a
Diluted EPS 5.01n/a
Sales per Share 24.32n/a
Book Value per Share 26.05n/a
FCF per Share 5.36n/a
Dividends per Share 0.20n/a
Price Multiples
Price to Earnings Ratio 40.13n/a
Price to Sales Ratio 8.45n/a
Price to Book Value 7.88n/a
Price to Free Cash Flow 38.37n/a
Valuation Metrics
EV/EBITDA 24.14n/a
EV/Sales 8.35n/a
Book to Market Value 0.12n/a
Other Ratios
Current Ratio 441.2%n/a
Liabilities to Equity Ratio 59.9%n/a
Debt to Assets Ratio 17.4%n/a
Profit & Loss StatementP&L data quality: 81% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14
Revenue
3,939
4,403
4,504
4,919
5,216
5,647
6,300
7,238
Sales & Services Revenue
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
-673
-761
-751
-722
-718
-751
-796
-842
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
3,266
3,642
3,753
4,197
4,498
4,895
5,505
6,396
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-2,520
-2,805
-2,774
-3,569
-3,116
-3,261
-3,678
-4,141
Selling, General & Administrative
-1,680
-1,856
-1,922
-2,627
-2,158
-2,193
-2,519
-2,837
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
-718
-798
-706
-805
-872
-977
-1,042
-1,192
Depreciation & Amortization
-121
-151
-146
-138
-86
-90
-117
-112
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
Operating Income (Loss)
746
837
979
628
1,382
1,635
1,826
2,254
Non-Operating Income (Loss)
-55
-34
-104
-88
-65
-80
-79
-20
Interest Expense, net
-29
-52
-70
-71
-65
-57
-68
-62
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-25
18
-34
-16
-1
-23
-10
42
Pretax Income (Loss), Adjusted
692
804
875
540
1,317
1,555
1,748
2,234
Abnormal Gains (Losses)
-26
-41
-76
-369
-8
-24
-17
-245
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
665
762
799
171
1,309
1,531
1,731
1,989
Income Tax (Expense) Benefit, net
-177
-198
-225
-166
-360
-430
-458
-457
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
488
565
575
5
950
1,101
1,273
1,533
Net Extraordinary Gains (Losses)
-2
0
0
0
-12
2
-284
-4
Discontinued Operations
-2
0
0
0
-12
2
-284
-4
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
486
565
575
5
938
1,103
989
1,529
Minority Interest
-1
-2
-3
-4
-4
-4
-4
-5
Net Income
486
563
572
1
935
1,099
985
1,524
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
486
563
572
1
935
1,099
985
1,524
Remarks
restated on Feb 26, 2010 n/a
calculated values,
restated on Mar 1, 2011 n/a
calculated values,
restated on Feb 28, 2012 n/a
calculated values,
restated on Feb 26, 2013 n/a
calculated values,
restated on Feb 25, 2014 n/a
calculated values,
restated on Feb 19, 2015 n/a
calculated values,
restated on Feb 19, 2015 n/a
calculated values,
restated on Feb 19, 2015 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
1,110
1,947
2,740
2,586
2,962
3,649
4,966
Cash & Cash Equivalents
n/a
1,110
1,947
1,991
2,406
2,702
3,046
4,911
Short Term Investments
n/a
0
0
749
180
261
603
55
Accounts & Notes Receivable
n/a
538
577
647
731
739
883
915
Accounts Receivable, Net
n/a
538
577
647
731
739
883
915
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
263
214
229
250
272
285
296
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
359
369
377
482
961
502
694
Prepaid Expenses
n/a
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
513
9
0
Miscellaneous Short Term Assets
n/a
359
369
377
482
449
493
694
Total Current Assets
n/a
2,271
3,106
3,994
4,048
4,935
5,320
6,871
Property, Plant & Equipment, Net
n/a
775
808
801
807
852
923
1,006
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
3,746
3,622
3,514
3,653
3,393
4,331
4,538
Intangible Assets
n/a
1,492
1,357
996
1,165
860
1,650
1,787
Goodwill
n/a
1,982
1,998
2,039
2,088
2,134
2,339
2,393
Other Intangible Assets
n/a
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
218
153
207
129
87
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
272
267
261
247
192
213
272
Total Noncurrent Assets
n/a
4,521
4,430
4,314
4,460
4,244
5,255
5,545
Total Assets
n/a
6,792
7,537
8,308
8,509
9,179
10,574
12,416
Liabilities and owners' equity
Payables & Accruals
n/a
693 692600000
794 793500000
858 857800000
871 871100000
1,041 1041400000
1,189 1188700000
1,485 1485200000
Accounts Payable
n/a
174 173900000
204 204000000
223 222500000
200 200400000
232 232200000
283 283200000
287 287400000
Accrued Taxes
n/a
49 49400000
43 42500000
16 16100000
0 0
0 0
39 38900000
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
469 469300000
547 547000000
619 619200000
671 670700000
809 809200000
867 866600000
1,198 1197800000
Short Term Debt
n/a
4 4400000
18 18100000
671 670600000
84 83900000
49 48800000
56 55600000
72 72100000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
5 5300000
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
5 5300000
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
697 697000000
812 811600000
1,528 1528400000
955 955000000
1,096 1095500000
1,244 1244300000
1,557 1557300000
Long Term Debt
n/a
1,571 1570500000
1,491 1491300000
1,534 1534200000
1,515 1515400000
1,512 1512400000
2,098 2098300000
2,085 2085300000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
472 471800000
390 389800000
464 464400000
706 705800000
709 708800000
762 762200000
1,010 1010100000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
69 69000000
1 1400000
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
403 402800000
388 388400000
464 464400000
706 705800000
709 708800000
762 762200000
1,010 1010100000
Total Noncurrent Liabilities
n/a
2,042 2042300000
1,881 1881100000
1,999 1998600000
2,221 2221200000
2,221 2221200000
2,861 2860500000
3,095 3095400000
Total Liabilities
n/a
2,739 2739300000
2,693 2692700000
3,527 3527000000
3,176 3176200000
3,317 3316700000
4,105 4104800000
4,653 4652700000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
2,600 2599700000
2,733 2733400000
2,819 2818600000
2,765 2764900000
2,904 2903700000
3,036 3035900000
3,357 3356800000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-192 -192400000
-165 -164500000
-134 -133900000
-183 -183200000
-654 -654100000
-993 -992800000
-1,090 -1090000000
Retained Earnings
n/a
1,842 1842100000
2,357 2356700000
2,226 2225900000
2,969 2969300000
3,832 3832100000
4,647 4646700000
5,895 5894800000
Other Equity
n/a
-199 -198700000
-103 -102800000
-153 -152900000
-241 -241400000
-245 -244600000
-227 -226600000
-409 -408600000
Equity Before Minority Interest
n/a
4,051 4050700000
4,823 4822800000
4,758 4757700000
5,310 5309600000
5,837 5837100000
6,463 6463200000
7,753 7753000000
Minority Interest
n/a
2 1800000
21 21100000
23 23400000
23 22800000
26 25500000
6 6300000
10 10000000
Total Equity
n/a
4,053 4052500000
4,844 4843900000
4,781 4781100000
5,332 5332400000
5,863 5862600000
6,470 6469500000
7,763 7763000000
Total Liabilities & Equity
n/a
6,792 6791800000
7,537 7536600000
8,308 8308100000
8,509 8508600000
9,179 9179300000
10,574 10574300000
12,416 12415700000
Remarks restated on n/a restated on Feb 26, 2010 n/a restated on Mar 1, 2011 n/a restated on Feb 28, 2012 n/a restated on Feb 26, 2013 n/a restated on Feb 25, 2014 n/a restated on Feb 19, 2015 n/a restated on Feb 19, 2015 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14
Net Income/Starting Line
485
565
624
5
938
1,103
989
1,529
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
216
264
262
257
253
257
255
248
Non-Cash Items
125
58
114
270
53
69
405
344
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
-33
-205
113
-68
-163
171
47
-193
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
Cash from Operating Activities
793
683
1,113
464
1,082
1,600
1,695
1,928
Change in Fixed Assets & Intangibles
-143
-259
-99
-143
-118
-146
-172
-258
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
28
75
1,142
785
683
1,796
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-660
-144
-13
-70
-101
-349
-849
-66
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
-31
-56
-15
-839
-582
-879
-1,037
-1,289
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
-834
-460
-99
-977
341
-589
-1,375
183
Dividends Paid
-61
-61
-61
-61
-61
-60
-59
-60
Cash From (Repayment of) Debt
-109
-35
-86
655
-778
-35
605
17
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-49
-179
-42
-52
-198
-663
-471
-318
Increase in Capital Stock
137
52
64
234
264
246
179
521
Decrease in Capital Stock
-187
-230
-106
-286
-462
-909
-651
-839
Other Financing Activities
36
11
7
21
35
41
-46
157
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
-182
-263
-182
563
-1,002
-718
28
-204
Net Cash Before Disc. Operations and FX
-223
-40
833
50
420
293
348
1,907
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
Net Cash Before FX
-223
-40
833
50
420
293
348
1,907
Effect of Foreign Exchange Rates
12
-8
4
-6
-6
3
-4
-41
Net Changes in Cash
-212
-48
837
44
415
296
344
1,865
Remarks
restated on Feb 26, 2010 n/a
calculated values,
restated on Mar 1, 2011 n/a
calculated values,
restated on Feb 28, 2012 n/a
calculated values,
restated on Feb 26, 2013 n/a
calculated values,
restated on Feb 25, 2014 n/a
calculated values,
restated on Feb 19, 2015 n/a
calculated values,
restated on Feb 19, 2015 n/a
calculated values,
restated on Feb 19, 2015 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo